Applications are invited for two Medical Statisticians, to join the Primary Care Clinical Trials Unit (PC-CTU) trial statistics team. The successful applicants will be expected to contribute to all statistical aspects of clinical trial activities within the PC-CTU and outside the PC-CTU.

You will hold a Postgraduate degree in statistics supported by a publication record.

You will be based in the Gibson Building, Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Woodstock Road, Oxford, OX2 6GG as your normal place of work but there may be the opportunity for occasional remote working which you need to agree a pattern of regular remote working with your line manager.

There are two positions available. The first position is offered for two years in the first instance. The second position is available for two years or until 30 September 2028, whichever is sooner. We welcome applications from candidates interested in either full-time or part-time work.

For further information or discuss the post please contact Dr Milensu Shanyinde.

Whilst the role is a grade 7 (£39,424 - £47,779 per annum) an appointment at grade 6 (£35,681 - £41,636 per annum) may be considered with an appropriate adjustment in duties, where an appointment at grade 7 cannot be made.

“Committed to equality and valuing diversity”

Applications for this vacancy are to be made online and you will be required to upload a CV and Supporting Statement as part of your online application. The Supporting Statement should include a cover letter and should also clearly describe how you meet each of the selection criteria listed in the job description. Click here for information and advice on writing an effective Supporting Statement. Please do not attach any manuscripts, papers, transcripts, mark sheets or certificates as these will not be considered as part of your application.

The closing date for applications is 12:00 noon on Wednesday 10 June 2026.

Interviews are expected to be held during the week commencing 6 July 2026.